CELLEGY PHARMACEUTICALS INC 4
4 · CELLEGY PHARMACEUTICALS INC · Filed Nov 8, 2004
Insider Transaction Report
Form 4
KARLIN DAVID A
VP, Clinical Research
Transactions
- Sale
Common Stock
2004-11-05$5.07/sh−1,000$5,070→ 5,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-11-08$1.92/sh+2,000$3,840→ 103,000 totalExercise: $1.92Exp: 2012-10-15→ Common Stock (2,000 underlying) - Sale
Common Stock
2004-11-05$4.99/sh−2,000$9,980→ 2,000 total - Exercise/Conversion
Common Stock
2004-11-08$1.92/sh+2,000$3,840→ 2,000 total
Footnotes (1)
- [F1]Stock option exercise from grant dated 10/15/2002; 25,000 vested immediately with remaining 125,000 vested in equal monthly installments over four years.